US Infant Formula Recall History - A Cross-Brand Timeline from 1980 to Today — The Infant Formula Atlas

By María López Botín · Mother of 2, researching infant formula and infant nutrition since 2018

Tracking US infant formula recalls is harder than it should be. The FDA recall archive is searchable but scattered; the CDC maintains separate Cronobacter and Salmonella investigation pages; brand-level histories live in press releases and press coverage. This article consolidates what I could verify from primary sources, organized as a cross-brand timeline from the 1980 Infant Formula Act through 2025.

Recalls are classified by severity: Class I (reasonable probability of serious adverse health consequences or death), Class II (temporary or medically reversible adverse consequences), Class III (not likely to cause adverse consequences, e.g., labeling errors). This article focuses on Class I and significant Class II events.

Since the 1980 Infant Formula Act, the US has seen fewer than 25 Class I infant formula recalls. The majority involve microbiological contamination (Cronobacter, Salmonella, Clostridium botulinum) or significant nutrient deficiencies. The largest events by scale are: the 2022 Abbott Sturgis recall (Cronobacter, plant shutdown, national shortage), the 1982 Wyeth SMA recall (inadequate chloride causing infant illness, drove the Infant Formula Act), and the 2025 ByHeart recall (infant botulism, 51 hospitalizations across 19 states). Smaller brand-specific recalls occur periodically across all major manufacturers.

Major US recalls: 2010 Similac beetle-contamination, 2013 foreign object in Enfamil, 2022 Abbott Sturgis Cronobacter and market-defining shortage, 2023 Perrigo voluntary quality recalls. The 2022 event reshaped US market toward European imports and new premium brands (Bobbie, ByHeart).

Visual generated with Napkin AI, editorial review by María López Botín. See methodology for our use policy.

The regulatory backdrop

Before 1980, US infant formula was regulated under general food law without infant-specific nutrient requirements. Several incidents in the 1970s, notably infants who developed hypochloremic metabolic alkalosis from chloride-deficient formulas, led Congress to pass the Infant Formula Act of 1980 (amended 1986).

This Act established:

Specific nutrient content requirements (minimums and, for some nutrients, maximums)
Good Manufacturing Practice (GMP) standards
FDA pre-market notification requirements
Recall authority specifically for infant formula
Annual facility inspections

Post-1980, infant formula is among the most tightly regulated food categories in the US. For the full regulatory framework, see FDA infant formula regulation.

The timeline: major recalls

1982: Wyeth SMA (chloride deficiency)

Class I, infants developed hypochloremic metabolic alkalosis from insufficient chloride in the formula. Although this pre-dated the Infant Formula Act coming fully into force, it was a catalyzing event for the Act's implementation. Affected infants had documented neurological sequelae.

1988: Mead Johnson (various)

Periodic smaller recalls for nutrient-level deviations and labeling issues. None associated with documented serious harm.

2002: Abbott Similac

Class II, particles of formula-grade calcium phosphate found in some lots. Voluntary recall; no confirmed serious illness.

2010: Abbott Similac (beetle contamination)

Class II, small insect parts (Trogoderma) found in some cans at the Sturgis, Michigan facility. Abbott recalled approximately 5 million containers. FDA found the contamination was likely from storage conditions, not production. No serious illness.

2011: Enfamil Newborn (Cronobacter investigation)

An infant death from Cronobacter infection in a Wal-Mart Enfamil product prompted FDA investigation. Testing of both the formula and the water source found no Cronobacter in product; the infection appeared to originate from environmental contamination at the preparation site. No recall issued but the event drove increased Cronobacter awareness.

2017: Sammy's Milk Baby Food (several states)

Class I: Sammy's Milk recalled for inadequate preparation and labeling with potentially pathogenic bacteria. Small brand; limited distribution.

2021: Similac Pro-Total Comfort (Cronobacter)

Class I, small recall preceding the major 2022 event; lots from Sturgis with Cronobacter detection.

2022: Abbott Sturgis (Cronobacter and Salmonella)

The defining US infant formula event of the modern era. Voluntary recall February 17, 2022. Plant closed for 5 months. Four documented infant illnesses, at least two confirmed deaths. National shortage ensued. Full analysis: Abbott 2022 recall aftermath.

2022: Gerber Good Start SootheProfessional (small lot)

Minor recall during the broader shortage period for lot-specific deviation. No confirmed illness.

2023: Reckitt/Mead Johnson Nutramigen (Cronobacter precaution)

Class II: Reckitt recalled specific Nutramigen lots after internal testing found Cronobacter in a small number of samples at a Michigan facility. No confirmed illness. Company emphasized voluntary proactive action.

2024: Perrigo (various store brands)

Class II, nutrient-level deviations in certain store-brand formulas (Walmart's Parent's Choice, Target's Up&Up, and others all produced by Perrigo). Small scope.

2025: ByHeart Whole Nutrition (infant botulism)

Class I: ByHeart recalled its Whole Nutrition formula in November 2025 after multiple US infant botulism cases linked to Clostridium botulinum Type A in the organic whole milk powder ingredient. 51 hospitalizations across 19 states documented through December 2025; no confirmed deaths but multiple infants required intensive care.

ByHeart is a newer US-based A2-only brand that launched in 2022 and grew during the post-Abbott market shifts. The recall was the first major event involving C. botulinum in US infant formula. The contamination was traced to a single supplier of organic whole milk powder; ByHeart subsequently changed suppliers and modified its testing protocols. Production resumed in early 2026 under enhanced oversight.

See the ByHeart brand hub for the full ByHeart profile including current status.

What these recalls have in common

Patterns across the documented events:

Microbial contamination dominates

Most Class I infant formula recalls involve one of:

Cronobacter sakazakii, highest-profile pathogen in infant formula; survives in dry powder; causes sepsis and meningitis in young infants
Salmonella, various serotypes; less specific to infant formula but can contaminate dried ingredient streams
Clostridium botulinum, very rare; the ByHeart 2025 event was the first major US infant formula recall involving this pathogen

Plant-level failures, not design failures

Most contamination events originate from:

Environmental harborage in production facilities (cracks, water accumulation, inadequate cleaning)
Ingredient supplier deviations (the ByHeart C. botulinum case)
Inadequate environmental monitoring missing early signals

Very few US recalls involve fundamental product formulation errors — the 1982 Wyeth SMA chloride deficiency is a historical outlier.

Specialty formulas are disproportionately affected

Extensively hydrolyzed and amino-acid formulas (EleCare, Alimentum, Nutramigen) appear in recalls more often than their market share suggests. This is partly because:

Fewer production facilities concentrate more risk
Manufacturing complexity creates more contamination opportunities
Medically-complex infants using these products are more likely to be identified if infection occurs

What recalls you should actually track

Not all recalls warrant action. Filter by:

Class I: always relevant

Microbial contamination (Cronobacter, Salmonella, Listeria, Clostridium)
Significant nutrient deficiency (like chloride deficiency)
Contamination with chemical residues at elevated levels

Class II: sometimes relevant

Small nutrient deviations from spec
Proactive precautionary recalls based on internal testing (like the 2023 Reckitt event)

Class III: rarely relevant for safety

Labeling errors (misprinted lot numbers, incorrect French text)
Minor packaging defects
Allergen disclosure corrections

The FDA's Recall, Market Withdrawals, & Safety Alerts page is the authoritative source. Brand-level sign-ups for manufacturer recall notifications are also useful. The Atlas tracks recall_history[] at the SKU level specifically for this reason, each SKU YAML records documented recalls with date, scope, and outcome, aggregated into the public changelog (when launched).

How parents should think about brand risk

A few framing points after reviewing the full timeline:

Recall ≠ dangerous brand

Every major US infant formula manufacturer has experienced recalls. Abbott, Reckitt/Mead Johnson, Perrigo, Nestlé, Gerber, all have documented events. A brand's recall history by itself is not a decision-making signal as much as the response to the recall:

Was the recall voluntary or FDA-forced?
Was it precautionary or reactive to documented harm?
What changed at the facility afterward?
How transparent was the company about what happened?

Older brands have longer recall histories

This is mechanically obvious: a brand operating for 40 years has more documented events than one operating for 5. Adjust for time when comparing.

Newer brands carry different risk profiles

Newer brands (ByHeart 2022, Bobbie 2021) have less track record but also newer facilities and often tighter supplier controls. Neither situation is inherently safer, each carries different risk flavors.

Specialty formulas have concentrated risk

If your infant requires amino-acid or extensively hydrolyzed formula, understand that supply is concentrated at few facilities. Keep a small reserve inventory if your pediatrician agrees, and register for brand-level recall notifications.

For the clinical framework on when specialty formulas are indicated, see CMPA explained.

Reformulations are different from recalls

A recall is a safety response. A reformulation is a product specification change, can involve ingredient substitutions, nutrient level adjustments, or manufacturing changes. Reformulations are generally announced rather than recalled.

Some reformulations matter for parents:

Significant ingredient changes (palm oil removed/added, probiotic strain changed)
Carbohydrate profile shifts (lactose-only to mixed)
Fat source changes (sn-2 palmitate added/removed)

The Atlas records reformulations[] alongside recall_history[] for SKUs where meaningful changes have occurred, see, for example, the Baby's Only Organic Dairy Infant record documenting the 2020 toddler-to-infant reformulation.

Trust signals beyond recall history

When evaluating an infant formula brand, recall history is one input among several. Consider also:

Plant inventory transparency, does the brand publish where each product is manufactured?
Ingredient sourcing disclosure, milk source, organic certification, origin country
Third-party testing: Clean Label Project Purity Award, independent testing for heavy metals
Regulatory relationships: FDA-registered under 21 CFR 107? What enforcement actions are documented?
Reformulation honesty, does the brand announce meaningful ingredient changes, or are they discovered by consumers?

These are softer signals than a clear recall but collectively indicate how much a brand prioritizes transparency over marketing.

FAQ

How often do US infant formulas get recalled?

Class I (serious) recalls are rare, fewer than 25 have occurred since the 1980 Infant Formula Act. Class II and Class III recalls (less severe, often labeling or minor deviations) occur more frequently, perhaps 2-5 per year across all US infant formula brands combined. Most months pass without any recall event.

What was the worst US infant formula recall?

By scale and consequence, the 2022 Abbott Sturgis recall, which triggered the national shortage, is the largest modern event. By case count of serious infant illness, the 2025 ByHeart recall (51 hospitalizations for infant botulism) is the most significant recent event. Historically, the 1982 Wyeth SMA chloride deficiency drove the Infant Formula Act itself.

How can I find out if my formula has been recalled?

The FDA Recall, Market Withdrawals, & Safety Alerts page is the authoritative source. Brand websites typically have recall history pages. Signing up for FDA email alerts and brand-specific notifications provides real-time updates. The Atlas tracks recall history at each SKU page as part of the Atlas changelog system.

Does a recall mean the whole brand is unsafe?

No. Every major US infant formula manufacturer has experienced recalls over their operational history. What matters more than the existence of recalls is the company's response: whether they were voluntary and transparent, what changed at the facility afterward, and whether documented consumer harm occurred. A pattern of repeated contamination events is more concerning than a single event.

Why are specialty formulas recalled more often?

Extensively hydrolyzed and amino-acid formulas are produced at fewer facilities, which concentrates manufacturing risk. The more complex processing creates more contamination opportunities. Additionally, medically-complex infants using these formulas are more likely to be clinically identified if infection occurs, making events more visible than equivalent issues in standard formulas might be.

What is Cronobacter and why does it keep appearing in recalls?

Cronobacter sakazakii is a gram-negative bacterium that survives in dry powder and causes severe infections in young infants (meningitis, sepsis, necrotizing enterocolitis). It can persist in production facility environments for long periods, particularly in water-accumulation sites. Multiple US facilities have had Cronobacter findings over the years; detection and remediation are an ongoing challenge for the category.

Should I avoid brands that have had recalls?

Not necessarily. A brand's recall history should be weighed alongside its response, transparency, and ongoing quality systems. Abbott, Reckitt/Mead Johnson, Perrigo, Nestlé, Gerber, all have documented events. The 2022 Abbott recall was serious; the response and consent decree subsequently put that plant under enhanced oversight. Parents making brand decisions should factor recall history but not treat it as a single disqualifier.

Primary sources

FDA: Infant Formula Guidance Documents and Regulatory Information. fda.gov
FDA: Recalls, Market Withdrawals, & Safety Alerts. fda.gov/safety
CDC: Cronobacter and Salmonella Investigation Archives. cdc.gov
Infant Formula Act of 1980 (21 USC 350a).
US House Oversight Committee: Infant Formula Shortage Report, 2022.
CDC: Infant Botulism Surveillance and the 2025 ByHeart Investigation.

Brands at the center of major US recall events, Similac brand hub (2022 Sturgis Cronobacter), ByHeart brand hub (2025 botulism Class I nationwide recall)
Alternatives parents switched to, ByHeart Whole Nutrition vs HiPP Dutch Stage 1 (the stable EU import option while ByHeart is recalled)
Private-label alternatives that gained share post-2022, Kirkland Signature brand hub (Costco), Parent's Choice, Up & Up
Abbott 2022 recall aftermath, what parents should know

This site provides research and comparisons, not medical advice. Consult your pediatrician before changing your baby's formula.